MedPath

Effects of Gum Arabic Supplementation in Hemodialysis Patients

Not Applicable
Conditions
Kidney Failure, Chronic
Interventions
Dietary Supplement: Gum Arabic
Other: Placebo
Registration Number
NCT03789708
Lead Sponsor
University of Khartoum
Brief Summary

Gum Arabic is a naturally produced gummy exudate from Acacia Senegal tree. It's a complex polysaccharide with proven prebiotic properties. Through its effect on intestinal bacteria, it's expected to reduce systemic levels of toxic bacterial metabolites and reduce inflammatory markers.By increasing fecal bacteria mass it's also expected to reduce blood urea level. These changes are potentially beneficial to hemodialysis patients who suffer from disturbed intestinal flora and a chronic inflammatory status. The investigators hypothesize that supplementing the diet of hemodialysis patients with Gum Arabic for four weeks would reduce inflammatory markers, increase total anti-oxidant capacity and reduce blood urea concentration.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Adult end-stage renal disease patients maintained on regular hemodialysis
Exclusion Criteria
  • Chronic liver disease
  • Malignant condition
  • Inflammatory bowel disease
  • History of bowel resection
  • Long term antibiotic therapy
  • Pregnancy or lactation
  • Current use of immunosuppressive medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AGum ArabicPatients will receive 10 g of Gum Arabic supplementation daily for four weeks. Gum Arabic is provided in the form of easily soluble granules. Participants are asked to dissolve it in water or juice and drink it.
CGum ArabicPatients will receive 20 g of Gum Arabic supplementation daily for four weeks
DGum ArabicPatients will receive 40 g of Gum Arabic supplementation daily for four weeks
BPlaceboPatients will receive 5 g of maltodextrin supplementation daily for four weeks. Maltodextrin is an easily digested polysacharide provided in the form of soluble whitish powder that has no taste or odor. Participants are asked to dissolve it in water or juice and drink it.
Primary Outcome Measures
NameTimeMethod
Highly sensitive C-reactive protein (hs CRP) level4 weeks

Change in serum level of highly sensitive C-reactive protein.

Total anti-oxidant capacity4 weeks

Change in serum total anti-oxidant capacity

Blood urea level4 weeks

Change in urea blood level

Secondary Outcome Measures
NameTimeMethod
Serum uric acid4 weeks

Change in serum uric acid level

Serum calcium4 weeks

Change in serum calcium level

Serum phosphorus4 weeks

Change in serum phosphorus level

Trial Locations

Locations (1)

Doctor Salma Center for Kidney Diseases

🇸🇩

Khartoum, Sudan

© Copyright 2025. All Rights Reserved by MedPath